In summary, our study further emphasizes the functional diversity among p53 mutations and reveals that partial-LOF mutations have a distinct translational impact on the course of tumorigenesis and cancer therapy and should be distinguished from classical hotspot mutations when using p53 mutations for predicting prognosis or deciding between treatment options. The gene discussed is TP53; the disease is cancer.